NKGen Biotech (NKGNW) Stock Price, News & Analysis

Company Overview

NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials. The company was founded in 2017 and is based in Santa Ana, California.

Key Stats

• Today's Range: $0.10 to $0.25
• 50-Day Range: $0.02 to $0.10
• 52-Week Range: $0.02 to $0.29
• Volume: 28,091 shs
• Average Volume: 18,433 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NKGNW Stock Analysis - Frequently Asked Questions

How have NKGNW shares performed this year?

NKGen Biotech's stock was trading at $0.0808 at the start of the year. Since then, NKGNW stock has increased by 23.8% and is now trading at $0.10.
View the best growth stocks for 2024 here.

How do I buy shares of NKGen Biotech?

Shares of NKGNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: NASDAQ:NKGNW
• CUSIP: N/A
• CIK: 1845459
• Web: nkgenbiotech.com
• Phone: 949-396-6830
• Fax: N/A
• Employees: 63
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $77,000.00
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A